JAK/STAT SIGNALING AS A MEDIATOR OF RESPONSE TO COMBINATION OF FLT3 AND MEK INHIBITORS IN ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Damnernsawad, Alisa [1 ]
Lerdwattanasombat, Pat [2 ]
Kraikhun, Panssachon [1 ]
Phanochit, Phanuphat [1 ]
Techo, Todsapol [3 ]
Bottomly, Daniel [4 ]
Nechiporuk, Tamilla [5 ]
McWeeney, Shannon [4 ]
Tyner, Jeffrey [5 ]
机构：
[1] Mahidol Univ, Dept Biol, Fac Sci, Bangkok, Thailand
[2] Mahidol Univ, Program Biomed Sci, Fac Sci, Bangkok, Thailand
[3] Khon Kaen Univ, Dept Biol, Fac Sci, Khon Kaen, Thailand
[4] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Bioinformat & Computat Biol, Portland, OR USA
[5] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Cell Dev & Canc Biol, Portland, OR USA
来源：
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2023年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：28 / 28
页数：1
相关论文
共 50 条
  • [31] Enhancing Therapeutic Efficacy of FLT3 Inhibitors with Combination Therapy for Treatment of Acute Myeloid Leukemia
    Leifheit, Malia E.
    Johnson, Gunnar
    Kuzel, Timothy M.
    Schneider, Jeffrey R.
    Barker, Edward
    Yun, Hyun D.
    Ustun, Celalettin
    Goldufsky, Josef W.
    Gupta, Kajal
    Marzo, Amanda L.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
  • [32] FOLLISTATIN IS A CRITICAL MEDIATOR FOR FLT3/ITD+ ACUTE MYELOID LEUKEMIA
    He, Bai-Liang
    Lam, Stephen
    Cher, Chae-Yin
    Ng, Nelson
    Leung, Anskar
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (09) : S79 - S79
  • [33] Incorporating FLT3 inhibitors into acute myeloid leukemia treatment regimens
    Pratz, Keith
    Levis, Mark
    LEUKEMIA & LYMPHOMA, 2008, 49 (05) : 852 - 863
  • [34] Advancing treatment of acute myeloid leukemia: the future of FLT3 inhibitors
    Elshoury, Amro
    Przespolewski, Amanda
    Baron, Jeffrey
    Wang, Eunice S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (03) : 273 - 286
  • [35] Clinical considerations for the use of FLT3 inhibitors in acute myeloid leukemia
    Weis, Taylor M.
    Marini, Bernard L.
    Bixby, Dale L.
    Perissinotti, Anthony J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 141 : 125 - 138
  • [36] Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia
    Short, Nicholas J.
    Kantarjian, Hagop
    Ravandi, Farhad
    Daver, Naval
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10
  • [37] Clinical Efficacies of FLT3 Inhibitors in Patients with Acute Myeloid Leukemia
    Song, Moo-Kon
    Park, Byeong-Bae
    Uhm, Ji-Eun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [38] Mechanisms Underlying Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia
    Eguchi, Motoki
    Minami, Yosuke
    Kuzume, Ayumi
    Chi, SungGi
    BIOMEDICINES, 2020, 8 (08)
  • [39] FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia The Start of an Era?
    Pemmaraju, Naveen
    Kantarjian, Hagop
    Ravandi, Farhad
    Cortes, Jorge
    CANCER, 2011, 117 (15) : 3293 - 3304
  • [40] Targeting FLT3 phosphorylation and signaling in acute myeloid leukemia.
    Ikeda, Alan K.
    Judelson, Dejah
    Li, Junling
    Wei, Ru Qi
    Tapang, Paul
    Davidsen, Steven K.
    Albert, Dan H.
    Glaser, Keith B.
    Fu, Cecilia
    Sakamoto, Kathleen M.
    BLOOD, 2007, 110 (11) : 278A - 278A
12345